Low-risk patients presented significantly higher levels of CD8 + T cells and macrophages M2, whereas CD4 + T cells, macrophages M0, and neutrophils were significantly lower in the low-risk group than in the high-risk group, indicating that systemic immune dysfunction in high-risk patients could impact their prognosis. This evidence concerns the gene CD8A and immune system disorder.